These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20619611)

  • 1. Effect of catechol-O-methyltransferase Val(108/158)Met polymorphism on antidepressant efficacy of fluvoxamine.
    Benedetti F; Dallaspezia S; Colombo C; Lorenzi C; Pirovano A; Smeraldi E
    Eur Psychiatry; 2010 Dec; 25(8):476-8. PubMed ID: 20619611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting.
    Benedetti F; Colombo C; Pirovano A; Marino E; Smeraldi E
    Psychopharmacology (Berl); 2009 Mar; 203(1):155-60. PubMed ID: 18989660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Catechol-O-methyltransferase Val(108/158)Met Genetic Polymorphism cannot be Recommended as a Biomarker for the Prediction of Venlafaxine Efficacy in Patients Treated in Psychiatric Settings.
    Taranu A; Asmar KE; Colle R; Ferreri F; Polosan M; David D; Becquemont L; Corruble E; Verstuyft C
    Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):435-441. PubMed ID: 28627776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin.
    Arias B; Serretti A; Lorenzi C; Gastó C; Catalán R; Fañanás L
    J Affect Disord; 2006 Feb; 90(2-3):251-6. PubMed ID: 16356553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute antidepressant response to sleep deprivation combined with light therapy is influenced by the catechol-O-methyltransferase Val(108/158)Met polymorphism.
    Benedetti F; Barbini B; Bernasconi A; Fulgosi MC; Dallaspezia S; Gavinelli C; Locatelli C; Lorenzi C; Pirovano A; Radaelli D; Smeraldi E; Colombo C
    J Affect Disord; 2010 Feb; 121(1-2):68-72. PubMed ID: 19520435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.
    Smeraldi E; Zanardi R; Benedetti F; Di Bella D; Perez J; Catalano M
    Mol Psychiatry; 1998 Nov; 3(6):508-11. PubMed ID: 9857976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of bipolar mania is associated with catechol-O-methyltransferase Val(108/158)Met polymorphism.
    Benedetti F; Dallaspezia S; Locatelli C; Radaelli D; Poletti S; Lorenzi C; Pirovano A; Colombo C; Smeraldi E
    J Affect Disord; 2011 Jul; 132(1-2):293-6. PubMed ID: 21397335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catechol-O-methyltransferase Val(108/158)Met polymorphism affects fronto-limbic connectivity during emotional processing in bipolar disorder.
    Vai B; Riberto M; Poletti S; Bollettini I; Lorenzi C; Colombo C; Benedetti F
    Eur Psychiatry; 2017 Mar; 41():53-59. PubMed ID: 28049082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of catechol-O-methyltransferase (rs4680) single-nucleotide polymorphism on opioid-induced hyperalgesia in adults with chronic pain.
    Hooten WM; Hu D; Cunningham JM; Black JL
    Mol Pain; 2019; 15():1744806919848929. PubMed ID: 31041874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.
    Szegedi A; Rujescu D; Tadic A; Müller MJ; Kohnen R; Stassen HH; Dahmen N
    Pharmacogenomics J; 2005; 5(1):49-53. PubMed ID: 15520843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between COMT Val158Met, childhood adversities and sex in predicting panic pathology: Findings from a general population sample.
    Asselmann E; Hertel J; Beesdo-Baum K; Schmidt CO; Homuth G; Nauck M; Grabe HJ; Pané-Farré CA
    J Affect Disord; 2018 Jul; 234():290-296. PubMed ID: 29574383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of catechol-O-methyltransferase (rs4680) single nucleotide polymorphisms with opioid use and dose among adults with chronic pain.
    Hooten WM; Biernacka JM; O'Brien TG; Cunningham JM; Black JL
    Pain; 2019 Jan; 160(1):263-268. PubMed ID: 30211780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter variation in the catechol-O-methyltransferase gene is associated with remission of symptoms during fluvoxamine treatment for major depression.
    Fukui N; Suzuki Y; Sugai T; Watanabe J; Ono S; Tsuneyama N; Someya T
    Psychiatry Res; 2014 Aug; 218(3):353-5. PubMed ID: 24814141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
    Cusin C; Serretti A; Zanardi R; Lattuada E; Rossini D; Lilli R; Lorenzi C; Smeraldi E
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):27-35. PubMed ID: 12057029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-specific associations among functional COMT Val
    Chang HA; Fang WH; Wan FJ; Tzeng NS; Liu YP; Shyu JF; Huang SY; Chang TC; Chang CC
    Psychoneuroendocrinology; 2019 Aug; 106():57-64. PubMed ID: 30954919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.
    Kato M; Zanardi R; Rossini D; De Ronchi D; Okugawa G; Kinoshita T; Colombo C; Serretti A
    Psychiatry Res; 2009 May; 167(1-2):97-105. PubMed ID: 19361869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manic symptom severity correlates with COMT activity in the striatum: A post-mortem study.
    Bortolato M; Walss-Bass C; Thompson PM; Moskovitz J
    World J Biol Psychiatry; 2017 Apr; 18(3):247-254. PubMed ID: 27458023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.
    Serretti A; Zanardi R; Rossini D; Cusin C; Lilli R; Smeraldi E
    Mol Psychiatry; 2001 Sep; 6(5):586-92. PubMed ID: 11526473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.